Abstract:OBJECTIVE:To study the impact of small interference RNA (siRNA) targeting cyclin A2 gene on the growth of MG-63 and HSF cells and to explore whether cyclin A2 siRNAs could become a useful tool in the treatment of osteosarcoma.METHODS:One pair of siRNA targeting the cyclin A2 mRNA and a pair of nonsense siRNA were designed according the current criteria. SiRNA was chemically synthesized and purified. The siRNA was transfected into osteosarcoma cell line MG-63 and normal human skin fibroblast (HSF) cells via oligofectamine. Cells transfected with nonsense siRNA served as the negative control and those only treated with PBS as the blank control group. Quantitative fluorescence RT-PCR, Western-blot, MTT assay, reverse transcriptase (RT)-PCR, flow cytometry and colony-forming test were employed to evaluate the efficacy of RNA interference. At the same time, the mRNA expression of PCNA and cyclin B1 in siRNA treated MG-63 cells were examined.RESULTS:1 nmol/L, 10 nmol/L, 50 nmol/L and 100 nmol/L cyclin A2-siRNA can reduced cyclin A2 mRNA and protein expression respectively by 9.43%, 56.35%, 79.17% and 84.30% as compared with that of the blank control group, whereas the negative and blank control groups had similar expression levels. After 48 h treatment with 10 nmol/L siRNA, MG-63 cells were arrested in G0/G1 phase and the proliferation of this tumor cell was suppressed by 39.06% 48 h after transfection. Furthermore, the treated MG-63 cells showed less colony-forming ability. Increasing the siRNA concentration to 50 nmol/L can further inhibit the proliferation of MG-63 cells by 54.94%. In addition, the cyclin A2-depleted MG-63 cells showed decreased levels of PCNA and cyclin B1. In contrast, although cyclin A2 mRNA and protein expression in HSF reduced 58.13% 48 h after treatment by 50 nmol/L siRNA, these cells exhibited only a slight change in cell cycle, and no clear inhibition of proliferation and impaired plate colony-forming ability was observed.CONCLUSION:Cyclin A2 gene maybe served as a potential target for tumor therapy. RNA interference induces obvious inhibition of cyclin A2 mRNA and protein expression in MG-63 and HSF cells, which consequently downregulate the proliferation of MG-63 cells. There is few inhibitory effect on the proliferation by siRNAs for HSF cells. These results indicate that siRNAs against cyclin A2 could become a potential antiproliferative tool in future antitumor therapy.

Differential Roles of SS18-SSX Fusion Gene and Insulin-Like Growth Factor-1 Receptor in Synovial Sarcoma Cell Growth.

Syt-Ssx Is Critical For Cyclin D1 Expression In Synovial Sarcoma Cells: A Gain Of Function Of The T(X;18)(P11.2;Q11.2) Translocation

The Effect of SYT-SSX and Extracellular Signal-Regulated Kinase (ERK) on Cell Proliferation in Synovial Sarcoma

Downregulation of Ss18-Ssx1 Expression by Small Interfering Rna Inhibits Growth and Induces Apoptosis in Human Synovial Sarcoma Cell Line Hs-Sy-Ii in Vitro

Expression and Function Evaluation of SYT-SSX1 and SYT-SSX2 Genes in Synovial Sarcoma

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery

The Clinical Implication of SS18 -SSX Fusion Gene in Synovial Sarcoma

Evaluation Of The Expression And Role Of Igf Pathway Biomarkers In Human Sarcomas

The Classification of SYT-SSX Fusion Genes in Synovial Sarcoma and the Correlation between the Type of Fusion Genes and Cell Cycle

The Relationship of SYT-SSX Fusion Genes with the Proliferation and Apoptosis of Tumor Cells in Synovial Sarcoma

The role of SYT-SSX fusion genes in the development of synovial sarcoma and their prognostic value

Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma

[Growth Inhibition of MG-63 Cells by Cyclin A2 Gene-Specific Small Interfering RNA].

SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma

Increased Expression of Insulin-Like Growth Factor-1 Receptor is Correlated with Tumor Metastasis and Prognosis in Patients with Osteosarcoma

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?

SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling

Gene Expression Profile by Blocking the SYT-SSX Fusion Gene in Synovial Sarcoma Cells. Identification of XRCC4 As a Putative SYT-SSX Target Gene

Anlotinib Inhibits Synovial Sarcoma by Targeting GINS1: a Novel Downstream Target Oncogene in Progression of Synovial Sarcoma.

Cell-of-origin epigenome underlies SS18::SSX-mediated transformation